Knowledge, attitude, and perception of public about participation in COVID-19 clinical trials: A study from Egypt and Saudi Arabia

BACKGROUND: Pharmaceutical firms are striving to find potential treatments to prevent and treat COVID-19. One of the gold standards to evaluate treatment is a clinical trial; however, the difficulty in patient recruitment could act as a determinant. It is evident from the registry data that very few...

Descripción completa

Detalles Bibliográficos
Autores principales: Elshammaa, Khaled, Hamza, Nouran, Elkholy, Emad, Mahrous, Ahmad, Hassan Elnaem, Mohamed, E Elrggal, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791234/
https://www.ncbi.nlm.nih.gov/pubmed/35103043
http://dx.doi.org/10.1016/j.jsps.2022.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791234/
https://www.ncbi.nlm.nih.gov/pubmed/35103043
http://dx.doi.org/10.1016/j.jsps.2022.01.008

Ejemplares similares